Amgen Antigen Binding Proteins Targeting Beta-Klotho and FGF Receptors

Sat, 18 Apr 2026 03:29:10 +0000
Intellectual Property

The European Patent Office granted Amgen Inc. Patent EP3760642A1 covering human antigen binding proteins that bind beta-Klotho, FGF receptors, and complexes thereof. The patent covers therapeutic applications including treatment of metabolic conditions (A61P 3/04). The patent is designated for all 31 European states including DE, FR, GB, IT, ES, NL, SE, and 21 others.